Amylin Pharmaceuticals Inc Watch

from 8-K 5 pages First Supplemental Indenture

from 10-K 3 pages Amended and Restated Promissory Note

from 10-K 13 pages Subsidiary Guarantee Agreement

from 10-K 57 pages Security Agreement Among Amylin Pharmaceuticals, Inc., Amylin Ohio LLC, Each of the Other Grantors Party Hereto and Eli Lilly and Company November 7, 2011

from 10-K 33 pages Amylin Pharmaceuticals, Inc. Secured Promissory Note

from 8-K 4 pages Second Amendment to Rights Agreement

from 8-K 30 pages Amylin Pharmaceuticals, Inc. 3.00% Convertible Senior Notes Due 2014 Registration Rights Agreement

from 8-K 105 pages Amylin Pharmaceuticals, Inc. Issuer the Bank of New York Trust Company, N.A. Trustee Indenture Dated as of June 8, 2007 3.00% Convertible Senior Notes Due 2014 Amylin Pharmaceuticals, Inc. Certain Sections of This Indenture Relating to Sections 310 Through 318 of the Trust Indenture Act of 1939

from 10-Q 31 pages Amylin Pharmaceuticals, Inc. 2.50% Convertible Senior Notes Due 2011 Registration Rights Agreement

from 10-Q 16 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company (55 Water Street, New York, New York) (The “Depositary”, Which Term Includes Any Successor Depositary for the Certificates) to the Company or Its Agent for Registration of Transfer, Exchange or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Requested by an Authorized Representative of the Depositary (And Any Payment Herein Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of the Depositary), Any Transfer, Pledge, or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein

from 10-Q 88 pages Amylin Pharmaceuticals, Inc. to J.P. Morgan Trust Company, National Association, as Trustee Indenture Dated as of April 6, 2004 2.50% Convertible Senior Notes Due 2011

from S-3 ~20 pages Amylin Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as Of

from S-3 ~20 pages Amylin Pharmaceuticals, Inc. and , as Warrant Agent Form of Depositary Shares Warrant Agreement Dated as Of

from S-3 ~20 pages Amylin Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as Of

from S-3 ~20 pages Amylin Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as Of

from S-3 ~50 pages Amylin Pharmaceuticals, Inc. Issuer and U.S. Bank National Association Trustee Indenture Dated as of December 11, 2003 Subordinated Debt Securities

from S-3 ~50 pages Amylin Pharmaceuticals, Inc. Issuer and U.S. Bank National Association Trustee Indenture Dated as of December 11, 2003 Senior Debt Securities

from S-3 ~20 pages Amylin Pharmaceuticals, Inc. and as Depositary and Holders of Depositary Receipts Deposit Agreement Dated as Of

from 10-Q 31 pages Amylin Pharmaceuticals, Inc. 2.25% Convertible Senior Notes Due 2008 Registration Rights Agreement

from 10-Q 15 pages This Note and Any Common Stock Issuable Upon the Conversion of This Note Have Not Been Registered Under the U.S. Securities Act of 1933, as Amended (The “Securities Act”), and May Not Be Sold or Otherwise Transferred in the Absence of Such Registration or an Applicable Exemption Therefrom. Each Purchaser of This Note Is Hereby Notified That the Seller of This Note May Be Relying on the Exemption From the Provisions of Section 5 of the Securities Act Provided by Rule 144a Thereunder